Most skin cancers are curable when caught early and treated promptly

The short answer is yes—most skin cancers can be cured, especially melanoma, basal cell carcinoma, and squamous cell carcinoma when found before they spread. Cure rates are highest when the cancer is still confined to the skin. A dermatologist removes the affected tissue, and the cancer does not return. The longer the cancer has been growing or the deeper it has spread into the body, the lower the cure rate becomes, though even advanced cases can sometimes be treated successfully.

What "curable" means in cancer medicine is specific: it means the cancer can be removed or destroyed and does not come back. For skin cancer, this is most likely in the first few years after diagnosis. Some people remain cancer-free for decades. Others develop a new skin cancer later—either a recurrence of the original or a separate cancer—which is why ongoing skin checks matter even after successful treatment.

Key Takeaways

  • Basal cell and squamous cell carcinomas have cure rates above 95 percent when treated in early stages, usually with a simple outpatient procedure.
  • Melanoma cure rates depend heavily on stage: stage 1 melanomas have cure rates around 95 percent, while stage 4 (metastatic) melanomas are much harder to cure but treatment options exist.
  • The depth of the cancer in the skin and whether it has spread to lymph nodes or other organs determine both treatment options and the likelihood of cure.
  • Even after successful treatment, skin cancer can return in the same spot or develop elsewhere on the body, so regular skin checks by a dermatologist are important.

How cure rates differ by skin cancer type

Basal cell carcinoma is the most common skin cancer and the easiest to cure. It grows slowly and rarely spreads beyond the skin. When a dermatologist removes it surgically—often in a single office visit—the cure rate is 95 to 99 percent. Recurrence at the same site happens in fewer than 5 percent of cases, usually within the first few years.

Squamous cell carcinoma is the second most common type and also highly curable in early stages. Cure rates for localized squamous cell carcinoma are 90 to 95 percent with surgical removal. This cancer grows faster than basal cell carcinoma and is more likely to spread to lymph nodes, especially if it started on the lips, ears, or genitals. When it has spread to nearby lymph nodes, treatment becomes more complex and cure rates drop, though remission is still possible.

Melanoma is less common but more dangerous because it spreads faster and deeper. A stage 1 melanoma (confined to the skin) has a five-year survival rate around 95 percent. Stage 2 melanomas (thicker or with other concerning features) have five-year survival rates of 80 to 90 percent. Stage 3 (spread to lymph nodes) drops to 40 to 70 percent depending on how many nodes are involved. Stage 4 melanoma (spread to distant organs) has a five-year survival rate around 20 to 30 percent, though newer immunotherapy drugs have improved outcomes in recent years.

What determines whether skin cancer can be cured

The depth of the cancer is the single most important factor. Skin cancers are measured in millimeters from the surface. A melanoma less than 1 millimeter thick has an excellent prognosis. One between 1 and 2 millimeters thick is still early but carries more risk. Beyond 4 millimeters, the cancer has likely reached deeper skin layers and is harder to cure completely. Basal cell and squamous cell carcinomas are staged differently—by size and location—but the same principle applies: smaller and shallower is better.

Whether the cancer has spread to lymph nodes or distant organs changes the picture significantly. If cancer cells are found in nearby lymph nodes, the cancer is considered stage 3, and treatment usually includes surgery plus radiation or systemic therapy (chemotherapy or immunotherapy). If cancer has spread to the lungs, liver, brain, or bones, it is stage 4, and cure becomes much less likely, though long-term remission is possible with newer treatments.

The location of the cancer also matters. Melanomas on the face, scalp, or hands tend to have worse outcomes than those on the trunk or limbs, possibly because they are often diagnosed later. Squamous cell carcinomas on the lips or ears are more aggressive than those on the trunk. Basal cell carcinomas rarely spread regardless of location.

How skin cancer is treated to achieve cure

For early-stage basal cell and squamous cell carcinomas, surgical excision is the standard treatment. A dermatologist removes the cancer and a margin of healthy skin around it, then closes the wound. The removed tissue is examined under a microscope to confirm all cancer cells are gone. This is often done in an office setting with local anesthesia and takes less than an hour. Cure rates with this approach are very high.

For melanoma, the approach depends on stage. A stage 1 melanoma is removed surgically with a wider margin than basal cell carcinoma—typically 1 to 2 centimeters of healthy skin around the cancer. The surgeon may also remove nearby lymph nodes and test them for cancer cells. If nodes are involved, adjuvant therapy (treatment after surgery to reduce recurrence risk) may include radiation, immunotherapy drugs like interferon or checkpoint inhibitors, or targeted therapy if a specific mutation is found.

For stage 3 and 4 melanomas, treatment is more aggressive. Immunotherapy drugs (checkpoint inhibitors such as pembrolizumab or nivolumab) have dramatically improved survival in recent years by helping the immune system recognize and destroy cancer cells. Targeted therapy works if the melanoma has a specific mutation like BRAF. Chemotherapy is used less often now but may be part of treatment in some cases. These systemic treatments can shrink tumors and extend survival, though cure at stage 4 remains uncommon.

What happens after treatment ends

After successful treatment, the cancer does not automatically return, but the risk is not zero. Local recurrence—cancer returning at the same spot—happens in a small percentage of cases, usually within the first two years. Regional recurrence—cancer appearing in nearby lymph nodes—is more common with melanoma than with basal or squamous cell carcinoma. Distant recurrence—cancer spreading to other parts of the body—is rare for basal cell carcinoma but possible for melanoma and squamous cell carcinoma.

People who have had skin cancer are also at higher risk of developing a new, separate skin cancer elsewhere on the body. This is not a recurrence of the original cancer but a new cancer, often caused by the same sun exposure that caused the first one. Regular skin checks—either self-examination monthly or professional examination by a dermatologist every 6 to 12 months—can catch new cancers early when they are most curable.

For melanoma patients, follow-up imaging (CT scans or PET scans) may be recommended depending on stage. For basal cell and squamous cell carcinomas, follow-up is usually clinical examination only, unless the cancer was large, deeply invasive, or in a high-risk location.

Factors that affect long-term outcomes

Age at diagnosis matters: younger people tend to have better long-term survival, though this may reflect earlier detection rather than biology. Immune function also plays a role—people with weakened immune systems (from HIV, organ transplant, or immunosuppressive medications) have worse outcomes with skin cancer and higher recurrence rates. Genetic factors influence risk: people with a family history of melanoma or those with fair skin, red or blonde hair, and light eyes have higher risk of developing skin cancer and sometimes develop multiple cancers over a lifetime.

Whether the person follows up with dermatology care after treatment is crucial. Missing follow-up appointments means new cancers or recurrences may not be caught until they are more advanced. People with a history of skin cancer should also take steps to reduce future risk: daily sunscreen (SPF 30 or higher), protective clothing, avoiding peak sun hours, and not using tanning beds.

When skin cancer is harder to cure

Skin cancers that have been growing for a long time before diagnosis are harder to cure because they have had time to grow deeper and spread. A melanoma that has been present for years before someone notices it is more likely to be thick and to have spread to lymph nodes. Cancers in immunocompromised people tend to be more aggressive and harder to treat. Squamous cell carcinomas that arise in areas of chronic sun damage, burn scars, or chronic wounds are more likely to be aggressive and to recur.

Some melanomas have genetic mutations that make them resistant to certain drugs. A melanoma with a BRAF mutation may respond well to targeted therapy, but one without it may not. Melanomas that have spread to the brain are particularly difficult to treat because drugs and radiation do not always penetrate brain tissue effectively. However, newer immunotherapy approaches have improved outcomes even in these difficult cases.

Frequently Asked Questions

Can basal cell carcinoma come back after it is removed?

Yes, but rarely. Recurrence happens in fewer than 5 percent of cases, usually within the first few years after treatment. Regular skin checks can catch a recurrence early. A new basal cell carcinoma in a different spot is more common than recurrence of the original cancer.

Is melanoma always fatal?

No. Most melanomas diagnosed in early stages are cured with surgery alone. Even stage 4 melanomas can be treated with immunotherapy or targeted therapy, and some people achieve long-term remission. Outcomes depend on stage at diagnosis, which is why early detection matters.

What is the difference between remission and cure in skin cancer?

Cure means the cancer is gone and does not return. Remission means the cancer has responded to treatment and is no longer detectable, but it may return later. In practice, skin cancer doctors often use "cure" for early-stage cancers with very low recurrence rates and "remission" for advanced cancers where recurrence is more likely.

If I had skin cancer once, will I definitely get it again?

No, but your risk is higher than someone who has never had skin cancer. People with a history of skin cancer are more likely to develop a new cancer, especially if they continue to have sun exposure. Using sunscreen, protective clothing, and regular skin checks reduce this risk.

Can immunotherapy cure stage 4 melanoma?

Immunotherapy can shrink stage 4 melanomas and extend survival significantly, but cure at stage 4 is uncommon. Some people achieve long-term remission lasting years or decades. Response varies by individual and by the specific characteristics of the cancer.